6 completed. 3 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Richard Crosby: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Motivational Interviewing for PrEP Uptake motivational interviewing - the Intervention Condition is a Brief Motivational Interviewing Session | Not applicable | Completed | Richard Crosby | 100 | 2016-01-03 | 2017-07-21 |
| Assessing Repeat Fit Testing for CRC Now I'm Telling You - Colo-rectal Cancer | Phase 3 | Completed | Richard Crosby | 220 | 2015-08-01 | 2019-02-21 |
| A Pilot Study of PrEP Acceptance Among Young Black MSM MI-PrEP, control condition - HIV Infection | Not applicable | Completed | Richard Crosby | 106 | 2015-01-05 | 2018-03-07 |
| Safer Sex Program for Young African-American Men Intervention - Gonorrhea, Chlamydia | Phase 2 | Completed | Richard Crosby | 620 | 2012-09-01 | 2019-02-21 |
| HIV Prevention Program for African American Teen Males Male Sexual Health Program, Focus on the Future Program - HIV Infections, Sexually Transmitted Infections | Not applicable | Completed | Richard Crosby | 840 | 2009-02-01 | 2017-07-14 |
| Effectiveness of HIV Risk Reduction Program Among African American Men Focus on the Future, Control standard of care treatment - Sexually Transmitted Diseases, HIV | Phase 3 | Completed | Richard Crosby | 270 | 2003-04-01 | 2013-12-16 |
HIV Infections (3) · Multiple Endocrine Neoplasia Type 1 (2) · Sexually Transmitted Diseases (2) · Chlamydia Infections (1) · Colonic Neoplasms (1) · Gonorrhea (1) · Syphilis (1) · Trichomonas Infections (1)
Methods (1) · Motivational Interviewing (1)
United States (3)
Richard A Crosby, PhD (2) · Andrew Forsythe, PhD (1) · Leandro A Mena, MD (1) · Ryan Pasternak, MD, MPH (1)
PMID 24898858, PMID 29419709, PMID 29534210
R01MH092226 (1), R21MH066682 (1)